Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Ticagrelor Added to Aspirin in Acute Ischemic Stroke or TIA in Prevention of Disabling Stroke
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
- Statins and In-Hospital Mortality in Diabetics With COVID-19
- Tocilizumab Efficacy in Hospitalized COVID-19 Patients
- Effect of Tocilizumab in Adults With COVID-19 and Pneumonia
- Early Treatment With Tocilizumab and Mortality in COVID-19
- Remdesivir for the Treatment of COVID-19
- Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19
- SGLT2 Inhibitors May Lower Risk of Major Adverse Cardiovascular Events
- Dapagliflozin in Patients With Chronic Kidney Disease